Theravance Biopharma, Inc. 4
4 · Theravance Biopharma, Inc. · Filed May 18, 2017
Insider Transaction Report
Form 4
Gunderson Robert V JR
Director
Transactions
- Award
Ordinary Shares
2017-05-17+6,000→ 35,059 total
Holdings
- 10,847(indirect: By Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP)
Ordinary Shares
Footnotes (1)
- [F1]Reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.